Walnut Creek, CA, United States of America

Ernst Chantraine


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 65(Granted Patents)


Location History:

  • Bergisch Gladbach, DE (2001)
  • Walnut Creek, CA (US) (2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Ernst Chantraine: Pioneering Pharmaceutical Innovations

Introduction

Ernst Chantraine, a distinguished inventor based in Walnut Creek, California, has made significant contributions to the field of pharmaceuticals. With a portfolio of two patents, Chantraine has focused on innovations that enhance the effectiveness and delivery of medicinal compounds.

Latest Patents

Chantraine's latest patents reflect his commitment to improving pharmaceutical preparations. One notable invention is the "Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same." This innovative system relates to orally administrable multiple-unit sustained-release dose forms designed to maintain controlled agitation-independent release of active compounds, employing a selected erodable hydrophilic polymer (HPC) while limiting the maximum size of the active compound-containing polymer particles to ≤3 mm.

Another significant patent is the "Osmotic medicament releasing system." This invention involves an orally administered osmotic drug release system that consists of a shell and a core containing a pharmaceutically active substance. The invention not only outlines the process for its production but also encompasses its use for the treatment and prevention of illnesses in both human beings and animals.

Career Highlights

Ernst Chantraine is currently associated with Bayer Aktiengesellschaft, a global leader in pharmaceuticals and life sciences. Throughout his career, he has demonstrated an unwavering dedication to pharmaceutical innovation, particularly in developing formulations that enhance drug delivery and efficacy.

Collaborations

Chantraine has collaborated with notable colleagues such as Erich Brendel and Claus Weisemann, furthering innovation in pharmaceutical technologies. These partnerships have contributed to the success and advancement of the projects they have worked on together.

Conclusion

As a pioneering inventor, Ernst Chantraine continues to influence the pharmaceutical industry through his inventive solutions. With an unwavering focus on enhancing drug delivery mechanisms, his contributions stand as a testament to the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…